NYSE:HCA

AREX Capital Expresses Disappointment in Enhabit’s Strategic Review Conclusion

Retrieved on: 
Thursday, May 9, 2024
Slate, Amedisys, CFO, ABA, Palliative care, Elevance Health, Speech, HCA Healthcare, Caesars Entertainment, Knowledge, Humana, ELV, Medicare, Health, Sale, Capital, HCA, BKD, LHC, History, Senior, Patient, Acquisition, Hospice, Interim, Annual general meeting, Audit, Nursing

NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- AREX Capital Management, LP (“AREX Capital Management” or “we”), together with its affiliates, the owners of approximately 4.8% of the shares of Enhabit, Inc. (NYSE: EHAB) (the “Company” or “Enhabit”), today issued the below statement expressing its disappointment in the conclusion of Enhabit’s strategic review.

Key Points: 
  • NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- AREX Capital Management, LP (“AREX Capital Management” or “we”), together with its affiliates, the owners of approximately 4.8% of the shares of Enhabit, Inc. (NYSE: EHAB) (the “Company” or “Enhabit”), today issued the below statement expressing its disappointment in the conclusion of Enhabit’s strategic review.
  • “We are disappointed that Enhabit’s strategic review process has concluded without a sale of the Company.
  • In March, we nominated a slate of seven highly qualified candidates to stand for election at the 2024 Annual Meeting.
  • He also served myNEXUS as a Vice Chairman and in a strategic advisor role from 2018 to 2019.

Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments

Retrieved on: 
Wednesday, April 24, 2024
MMS, Patient, AI, HCA, Innovation, MD, HCA Healthcare, Workflow, Documentation, SVP, Physician, EDS, MBA, ED, SAN, Architecture

SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of Augmedix Go for emergency departments (EDs), marking the launch of the industry’s first fully-automated, generative AI (GenAI) powered medical documentation product for EDs across the country.

Key Points: 
  • SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of Augmedix Go for emergency departments (EDs), marking the launch of the industry’s first fully-automated, generative AI (GenAI) powered medical documentation product for EDs across the country.
  • As part of the pilot, ED physicians in four HCA Healthcare hospitals utilized Augmedix Go to automate medical documentation, with the product instantaneously drafting their medical notes from patient visits.
  • “Using Augmedix allowed me to spend more time with my patients and less time in front of my computer.
  • These AI models are utilized across different specialties and sections of the note to deliver high quality medical documentation.

HCA Healthcare Reports First Quarter 2024 Results

Retrieved on: 
Friday, April 26, 2024
Other Health, Hospitals, Health, Practice Management, Health Technology, HCA, Public expenditure, Sale, Webcast, Adjustment, Central Time, HCA Healthcare

HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2024.

Key Points: 
  • HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2024.
  • Net income attributable to HCA Healthcare, Inc. totaled $1.591 billion, or $5.93 per diluted share
    “The strong fundamentals we saw in our business this past year continued into the first quarter of 2024.
  • Revenues in the first quarter of 2024 totaled $17.339 billion, compared to $15.591 billion in the first quarter of 2023.
  • For the first quarter of 2024, Adjusted EBITDA totaled $3.353 billion, compared to $3.172 billion in the first quarter of 2023.

Clinical Trial by Harvard Pilgrim Health Care Institute, HCA Healthcare, UCI Health and CDC Identifies Strategy to Rapidly Detect and Respond to Hospital Outbreaks Using Algorithm-Driven Technology

Retrieved on: 
Tuesday, April 23, 2024
Data Management, Other Health, Technology, Managed Care, General Health, Infectious Diseases, Hospitals, Clinical Trials, Other Technology, Biotechnology, Science, Software, Networks, Other Science, Research, Health, University, Hospital, Risk, CDC, University of California, HCA Healthcare, Patient safety, Fungal infection, Doctor of Science, Patient, MPH, UCI, NEJM, Harvard Medical School, Infection, Harvard Pilgrim Health Care, Doctor of Public Health, Senior advisor, COVID-19, CLUSTER, Vaccine

The large multi-state, real-world study was conducted in 82 hospitals and led by Harvard Pilgrim Health Care Institute, HCA Healthcare, University of California, Irvine (UCI) Health and the Centers for Disease Control and Prevention (CDC).

Key Points: 
  • The large multi-state, real-world study was conducted in 82 hospitals and led by Harvard Pilgrim Health Care Institute, HCA Healthcare, University of California, Irvine (UCI) Health and the Centers for Disease Control and Prevention (CDC).
  • While hospitals and health systems work to prevent infections and reduce the opportunity for outbreaks to occur, there is no standardized approach for detecting transmission.
  • Early detection can lead to a rapid response that reduces the chance for outbreaks to occur.
  • “The CLUSTER trial provides evidence that early detection powered by automation tools and quick action can prevent outbreaks from growing."

Fortune Names HCA Healthcare One of the World’s Most Admired Companies

Retrieved on: 
Monday, April 22, 2024
Biotechnology, Nursing, Managed Care, General Health, Health, Hospitals, Clinical Trials, Other Health, Methodist Hospital, Sky Ridge Medical Center, Korn Ferry, Hospital, HCA, HCA Florida Kendall Hospital, HCA Healthcare, Water, Ogden Regional Medical Center, Trinity, Documentation, Patient, Grand Strand Medical Center, Medicare, Social responsibility, Medical Center

HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced it has been named on Fortune’s 2024 World’s Most Admired Companies list.

Key Points: 
  • HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced it has been named on Fortune’s 2024 World’s Most Admired Companies list.
  • To determine this year’s list, Fortune collaborated with Korn Ferry to analyze 660 companies across 52 industries in 29 countries.
  • “It is a great honor to be included alongside other industry leaders on Fortune’s World’s Most Admired list this year,” said Sam Hazen, CEO of HCA Healthcare.
  • In addition to being a World’s Most Admired Company, 36 HCA Healthcare hospitals were named on the 2024 Fortune/PINC AI 100 Top Hospitals list.

Two Clinical Trials Identify a Better Way to Target Appropriate Antibiotics for Patients Hospitalized With Pneumonia or Urinary Tract Infection

Retrieved on: 
Friday, April 19, 2024
Research, Infectious Diseases, Hospitals, Clinical Trials, Other Health, Health, Pharmaceutical, General Health, Science, Epidemiology, UTI, Infection, Physician, Harvard University, University, Urinary tract infection, JAMA, Pneumonia, Risk, Hospital, CDC, Bacteria, American Medical Association, Health care, INSPIRE, HCA Healthcare, Workflow, Patient, COVID-19, MPH, UCI, Fungus, Assistant, Harvard Pilgrim Health Care, Harvard Medical School, Journal, Division, Pharmaceutical industry

The two newly published studies, the INSPIRE Pneumonia and UTI Trials, involved more than 220,000 patients with pneumonia or UTI in 59 HCA Healthcare hospitals.

Key Points: 
  • The two newly published studies, the INSPIRE Pneumonia and UTI Trials, involved more than 220,000 patients with pneumonia or UTI in 59 HCA Healthcare hospitals.
  • This resulted in a better match for 28% of pneumonia patients and 17% of patients with UTI when compared to hospitals where physicians were not provided with alerts according to the trials.
  • The INSPIRE trials identified patients with low risk for antibiotic resistance and prompted physicians to order standard-spectrum antibiotics if extended-spectrum antibiotics were being ordered.
  • Additional information about the INSPIRE Pneumonia and UTI Trials can be found in the following JAMA author interview podcast.

HCA Healthcare, Inc. to Present at May Healthcare Conferences

Retrieved on: 
Wednesday, April 3, 2024
Health, Hospitals, Surgery, Other Health, Managed Care, General Health, PDT, Conference, CDT, HCA, Bank, EDT, HCA Healthcare, Hotel

HCA Healthcare, Inc. (NYSE:HCA), is scheduled to present at the following healthcare conferences:

Key Points: 
  • HCA Healthcare, Inc. (NYSE:HCA), is scheduled to present at the following healthcare conferences:
    May 14, 2024 at 10:00 am PDT at the Bank of America Securities Conference at the Encore in Las Vegas, NV.
  • May 28, 2024 at 3:15 pm CDT at the 2024 Leerink Partners Healthcare Crossroads Conference at the Omni Barton Creek in Austin, TX.
  • May 30, 2024 at 11:00 am EDT at Bernstein’s 40th Annual Strategic Decisions Conference at the Hilton Midtown in New York, NY.
  • Dates and times may be subject to change, please check the conference schedule or the Investor Relations section of the Company’s website for the latest information.

HCA Healthcare Releases 2024 Annual Impact Report

Retrieved on: 
Thursday, March 28, 2024
Nursing, Practice Management, Health, Philanthropy, Other Philanthropy, Health Technology, Research, Hospitals, Surgery, Foundation, Science, Cloud, GME, Google Cloud, Disaster, Health equity, Patient, Ethics, ADGP, Investment, AAPD, American Red Cross, HCA Healthcare, Funding, Education, UCR, EEOC, Graduate medical education, Organization, Documentation, HCA, Red, Knowledge, Hospital, NHS primary care trust, Student, Galen College of Nursing, Growth, Environment, Food, Disability, Nursing care plan, Ethisphere Institute, Heart, EHR, Physician

HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced the release of its annual Impact Report that reflects on the past year and highlights HCA Healthcare’s positive impact across the communities it serves.

Key Points: 
  • HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced the release of its annual Impact Report that reflects on the past year and highlights HCA Healthcare’s positive impact across the communities it serves.
  • “At HCA Healthcare, our purpose is clear: We exist to give people a healthier tomorrow,” said Sam Hazen, CEO of HCA Healthcare.
  • Last year, 32 HCA Healthcare hospitals were recognized on the Fortune/PINC AI 100 Top Hospitals list, and in early 2024, 54 HCA Healthcare hospitals were included on Healthgrades’ 250 Best Hospitals list for clinical excellence.
  • For more information about the annual HCA Healthcare Impact Report, visit HCAhealthcareImpact.com .

HCA Healthcare, Inc. 1st Quarter 2024 Earnings Conference Call

Retrieved on: 
Monday, March 25, 2024
Health, Hospitals, Practice Management, Other Health, Managed Care, General Health

If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx .

Key Points: 

If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx .
View source version on businesswire.com: https://www.businesswire.com/news/home/20240325707215/en/

HCA Healthcare Names Dr. Monique Butler as President of Graduate Medical Education

Retrieved on: 
Tuesday, March 12, 2024
General Health, Surgery, Other Health, Hospitals, Health, GME, University, Growth, Communication, Business, Business administration, Wayne State University, HCA, Accreditation, Hospital, History, Faculty, Sinai-Grace Hospital, Butler, Detroit Receiving Hospital, University of Tennessee, Swedish Health Services, HCA Healthcare, Multimedia, Graduate medical education, Physician, Movement

HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that Dr. Monique Butler has been appointed president of Graduate Medical Education, effective March 1, 2024.

Key Points: 
  • HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that Dr. Monique Butler has been appointed president of Graduate Medical Education, effective March 1, 2024.
  • Dr. Butler succeeds Dr. Bruce Deighton who will retire from HCA Healthcare later in 2024.
  • “Dr.
  • Dr. Butler joined HCA Healthcare in 2018 as the chief medical officer of Swedish Medical Center.